Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Lipodystrophy and APOE[original query] |
|---|
| The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy. AIDS research and human retroviruses 2011 Dec 27 (12): 1299-309. Marzocchetti Angela, Schwarz Jessica, Di Giambenedetto Simona, Colafigli Manuela, Bracciale Laura, Fabbiani Massimilliano, Fantoni Massimo, Trecarichi Enrico, Cauda Roberto, De Luca Andr |
| Polymorphisms of the ApoE (Apolipoprotein E) gene and their influence on dyslipidemia in HIV-1-infected individuals. Japanese journal of infectious diseases 2015 68 (1): 5-12. Suwalak Tanida, Srisawasdi Pornpen, Puangpetch Apichaya, Santon Siwalee, Koomdee Napatrupron, Chamnanphon Montri, Charoenyingwattana Angkana, Chantratita Wasun, Sukasem Chonlaph |
| Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics. World journal of virology 2015 Aug 4 (3): 169-77. Asensi Victor, Collazos Julio, Valle-Garay Eulal |
| Correlation of APOE polymorphism, expression, and plasma levels with cardiac comorbidities among lipodystrophy in HIV-infected patients. Clinica chimica acta; international journal of clinical chemistry 2024 9 565 119969. Shyamveer, A Antony Jenitha, Meenakshi Bhattacharya, Supriya D Mahajan, Nemat Ali, Mohammad Rashid Khan, HariOm Sin |
- Page last reviewed:Feb 1, 2024
- Content source: